Follow
Daniel Spratt
Daniel Spratt
University Hospitals Seidman Cancer Center/CWRU
Verified email at uhhospitals.org
Title
Cited by
Cited by
Year
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
JL Mohler, ES Antonarakis, AJ Armstrong, AV D’Amico, BJ Davis, T Dorff, ...
Journal of the National Comprehensive Cancer Network 17 (5), 479-505, 2019
11782019
Genomic hallmarks and structural variation in metastatic prostate cancer
DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ...
Cell 174 (3), 758-769. e9, 2018
6272018
Androgen receptor signaling regulates DNA repair in prostate cancers
WR Polkinghorn, JS Parker, MX Lee, EM Kass, DE Spratt, PJ Iaquinta, ...
Cancer discovery 3 (11), 1245-1253, 2013
5212013
International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery
BW Cox, DE Spratt, M Lovelock, MH Bilsky, E Lis, S Ryu, J Sheehan, ...
International Journal of Radiation Oncology* Biology* Physics 83 (5), e597-e605, 2012
5192012
A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy
ZS Zumsteg, DE Spratt, I Pei, Z Zhang, Y Yamada, M Kollmeier, ...
European urology 64 (6), 895-902, 2013
3962013
Association of black race with prostate cancer–specific and other-cause mortality
RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ...
JAMA oncology 5 (7), 975-983, 2019
3442019
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
A Bosch, Z Li, A Bergamaschi, H Ellis, E Toska, A Prat, JJ Tao, DE Spratt, ...
Science translational medicine 7 (283), 283ra51-283ra51, 2015
3402015
NCCN guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines
E Schaeffer, S Srinivas, ES Antonarakis, AJ Armstrong, JE Bekelman, ...
Journal of the National Comprehensive Cancer Network 19 (2), 134-143, 2021
3392021
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 …
AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ...
Jama 319 (9), 896-905, 2018
2992018
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
DE Spratt, X Pei, J Yamada, MA Kollmeier, B Cox, MJ Zelefsky
International Journal of Radiation Oncology* Biology* Physics 85 (3), 686-692, 2013
2992013
Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies
WC Jackson, J Silva, HE Hartman, RT Dess, AU Kishan, WH Beeler, ...
International Journal of Radiation Oncology* Biology* Physics 104 (4), 778-789, 2019
2902019
Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis
R Morrison, SM Schleicher, Y Sun, KJ Niermann, S Kim, DE Spratt, ...
Journal of oncology 2011, 2011
2892011
Racial/ethnic disparities in genomic sequencing
DE Spratt, T Chan, L Waldron, C Speers, FY Feng, OO Ogunwobi, ...
JAMA oncology 2 (8), 1070-1074, 2016
2832016
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report
DE Spratt, WH Beeler, FY de Moraes, LD Rhines, JJ Gemmete, ...
The Lancet Oncology 18 (12), e720-e730, 2017
2682017
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
2622017
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer
AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ...
JAMA network open 2 (2), e188006-e188006, 2019
2572019
The DNA methylation landscape of advanced prostate cancer
SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ...
Nature genetics 52 (8), 778-789, 2020
2292020
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
MJ Morris, SP Rowe, MA Gorin, L Saperstein, F Pouliot, D Josephson, ...
Clinical Cancer Research 27 (13), 3674-3682, 2021
2182021
Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015
BA Mahal, S Butler, I Franco, DE Spratt, TR Rebbeck, AV D’Amico, ...
Jama 321 (7), 704-706, 2019
2182019
Individual patient-level meta-analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease
DE Spratt, K Yousefi, S Deheshi, AE Ross, RB Den, EM Schaeffer, ...
Journal of Clinical Oncology 35 (18), 1991, 2017
2112017
The system can't perform the operation now. Try again later.
Articles 1–20